- Home
- Publications
- Publication Search
- Publication Details
Title
Interleukin 2 in the Pathogenesis and Therapy of Type 1 Diabetes
Authors
Keywords
Tolerance, Immunotherapy, Autoimmune disease, Inflammation, Pharmacokinetics
Journal
Current Diabetes Reports
Volume 14, Issue 12, Pages -
Publisher
Springer Nature
Online
2014-10-25
DOI
10.1007/s11892-014-0553-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sustained stimulation and expansion of Tregs by IL2 control autoimmunity without impairing immune responses to infection, vaccination and cancer
- (2014) Guillaume Churlaud et al. CLINICAL IMMUNOLOGY
- Effects of Low-Dose Recombinant Interleukin 2 to Promote T-Regulatory Cells in Alopecia Areata
- (2014) Emeline Castela et al. JAMA Dermatology
- Limitations of IL-2 and Rapamycin in Immunotherapy of Type 1 Diabetes
- (2013) Audrey Baeyens et al. DIABETES
- Teplizumab (Anti-CD3 mAb) Treatment Preserves C-Peptide Responses in Patients With New-Onset Type 1 Diabetes in a Randomized Controlled Trial: Metabolic and Immunologic Features at Baseline Identify a Subgroup of Responders
- (2013) K. C. Herold et al. DIABETES
- B-Lymphocyte Depletion With Rituximab and -Cell Function: Two-Year Results
- (2013) M. D. Pescovitz et al. DIABETES CARE
- Costimulation Modulation With Abatacept in Patients With Recent-Onset Type 1 Diabetes: Follow-up 1 Year After Cessation of Treatment
- (2013) Tihamer Orban et al. DIABETES CARE
- The IL-2/IL-2R system: from basic science to therapeutic applications to enhance immune regulation
- (2013) Allison L. Bayer et al. IMMUNOLOGIC RESEARCH
- Multiple Autoimmune-Associated Variants Confer Decreased IL-2R Signaling in CD4+CD25hi T Cells of Type 1 Diabetic and Multiple Sclerosis Patients
- (2013) Karen Cerosaletti et al. PLoS One
- Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial
- (2013) Agnès Hartemann et al. Lancet Diabetes & Endocrinology
- Levels of peripheral CD4+FoxP3+ regulatory T cells are negatively associated with clinical response to adoptive immunotherapy of human cancer
- (2012) X. Yao et al. BLOOD
- Rapamycin/IL-2 Combination Therapy in Patients With Type 1 Diabetes Augments Tregs yet Transiently Impairs -Cell Function
- (2012) S. A. Long et al. DIABETES
- Administration of CD4+CD25highCD127- Regulatory T Cells Preserves -Cell Function in Type 1 Diabetes in Children
- (2012) N. Marek-Trzonkowska et al. DIABETES CARE
- Listeria monocytogenes Cytoplasmic Entry Induces Fetal Wastage by Disrupting Maternal Foxp3+ Regulatory T Cell-Sustained Fetal Tolerance
- (2012) Jared H. Rowe et al. PLoS Pathogens
- Regulatory T Helper Cells in Pregnancy and their Roles in Systemic versus Local Immune Tolerance
- (2011) Jan Ernerudh et al. AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
- Rapamycin Causes Upregulation of Autophagy and Impairs Islets Function Both In Vitro and In Vivo
- (2011) M. Tanemura et al. AMERICAN JOURNAL OF TRANSPLANTATION
- T-cell tolerance and the multi-functional role of IL-2R signaling in T-regulatory cells
- (2011) Guoyan Cheng et al. IMMUNOLOGICAL REVIEWS
- Inducible Adeno-Associated Virus-Mediated IL-2 Gene Therapy Prevents Autoimmune Diabetes
- (2011) K. S. Goudy et al. JOURNAL OF IMMUNOLOGY
- Rapamycin induces glucose intolerance in mice by reducing islet mass, insulin content, and insulin sensitivity
- (2011) Shi-Bing Yang et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial
- (2011) Tihamer Orban et al. LANCET
- Immunomodulatory therapy to preserve pancreatic β-cell function in type 1 diabetes
- (2011) Frank Waldron-Lynch et al. NATURE REVIEWS DRUG DISCOVERY
- Regulatory T-Cell Responses to Low-Dose Interleukin-2 in HCV-Induced Vasculitis
- (2011) David Saadoun et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease
- (2011) John Koreth et al. NEW ENGLAND JOURNAL OF MEDICINE
- An autoimmune-associated variant in PTPN2 reveals an impairment of IL-2R signaling in CD4+ T cells
- (2010) S A Long et al. GENES AND IMMUNITY
- IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells
- (2010) Yenkel Grinberg-Bleyer et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Nonobese Diabetic Congenic Strain Analysis of Autoimmune Diabetes Reveals Genetic Complexity of the Idd18 Locus and Identifies Vav3 as a Candidate Gene
- (2010) H. I. Fraser et al. JOURNAL OF IMMUNOLOGY
- CD4+CD25+ Regulatory T Cell Depletion Improves the Graft-Versus-Tumor Effect of Donor Lymphocytes After Allogeneic Hematopoietic Stem Cell Transplantation
- (2010) S. Maury et al. Science Translational Medicine
- Rapamycin Prevents and Breaks the Anti-CD3-Induced Tolerance in NOD Mice
- (2009) A. Valle et al. DIABETES
- Genome-Wide Scan for Linkage to Type 1 Diabetes in 2,496 Multiplex Families From the Type 1 Diabetes Genetics Consortium
- (2009) P. Concannon et al. DIABETES
- Defects in IL-2R Signaling Contribute to Diminished Maintenance of FOXP3 Expression in CD4+CD25+ Regulatory T-Cells of Type 1 Diabetic Subjects
- (2009) S. A. Long et al. DIABETES
- A Low Interleukin-2 Receptor Signaling Threshold Supports the Development and Homeostasis of T Regulatory Cells
- (2009) Aixin Yu et al. IMMUNITY
- Massive expansion of regulatory T-cells following interleukin 2 treatment during a phase I-II dendritic cell-based immunotherapy of metastatic renal cancer
- (2009) Lemoine INTERNATIONAL JOURNAL OF ONCOLOGY
- Regulatory T cells exert checks and balances on self tolerance and autoimmunity
- (2009) Kajsa Wing et al. NATURE IMMUNOLOGY
- Interleukin-2 Therapy in Patients with HIV Infection
- (2009) NEW ENGLAND JOURNAL OF MEDICINE
- Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function
- (2009) Mark D. Pescovitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Homeostatic imbalance of regulatory and effector T cells due to IL-2 deprivation amplifies murine lupus
- (2009) J. Y. Humrich et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Correlation of clinical and virologic responses to antiviral treatment and regulatory T cell evolution in patients with hepatitis C virus-induced mixed cryoglobulinemia vasculitis
- (2008) Dan-Avi Landau et al. ARTHRITIS AND RHEUMATISM
- Regulatory T Cells and Immune Tolerance
- (2008) Shimon Sakaguchi et al. CELL
- Central Role of Defective Interleukin-2 Production in the Triggering of Islet Autoimmune Destruction
- (2008) Qizhi Tang et al. IMMUNITY
- The IL-2/CD25 Pathway Determines Susceptibility to T1D in Humans and NOD Mice
- (2008) Calliope A. Dendrou et al. JOURNAL OF CLINICAL IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation